BZAM's Medical Cannabis Products To Reach UK Market Via 4C LABS
Portfolio Pulse from Vuk Zdinjak
BZAM Ltd. has announced that its subsidiary, The Green Organic Dutchman Ltd., has entered into a strategic distribution agreement with 4C LABS Ltd. to commercialize medical cannabis products in the UK starting in Q4 2023. BZAM will supply 4C LABS with approximately 600kg of flower annually for the next two years.
May 23, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BZAM Ltd. enters into a strategic distribution agreement with 4C LABS to commercialize medical cannabis products in the UK, potentially increasing revenues.
The strategic distribution agreement between BZAM Ltd. and 4C LABS will allow BZAM to commercialize its medical cannabis products in the UK market, starting in Q4 2023. This partnership has the potential to increase BZAM's revenues as it expands its market reach and supplies 4C LABS with approximately 600kg of flower annually for the next two years.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100